Navigation Links
Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis

er factors that may cause the actual results of Accentia to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for product candidates; competition from other pharmaceutical or biotechnology companies; and the additional risks discussed in filings with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement, and Accentia undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.

Contact

Accentia Biopharmaceuticals, Inc., Tampa, FL
Susan Bonitz, Ph.D., 813-864-2554-Extension 277
sbonitz@accentia.net
or
Investors:
The Investor Relations Group, New York
Adam S. Holdsworth, 212-825-3210
aholdsworth@investorrelationsgroup.com
or
Media:
Janet Vasquez, 212-825-3210
jvasqyez@investorrelationsgroup.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:11/27/2008)...w study finds the majority of acute lymphoblastic ...resent at the time of diagnosis , , MEMPHIS...ists at St. Jude Children,s Research Hospital have...cer cells of children with acute lymphoblastic leu... a pathway to designing treatments for ALL relapse...
(Date:11/25/2008)...mptom awareness can improve recovery , , Au...y are available on the Mayo Clinic News Blog. Plea... , , ROCHESTER, Minn., Nov. 25 /PRNewswire...ty of stroke patients don,t think they,re having a...ent until their condition worsens. The findings ap...
(Date:11/25/2008)...UTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-Fir... PARD ), a biopharmaceutical company focused on,...at it will be exploring,strategic alternatives fo...low,the Company to focus its resources on the cli... candidate, and to support the initial commerciali...
(Date:11/24/2008)...ERFIELD, Ill., and OSAKA, Japan, Nov. 24 /PRNewswi...ts wholly-owned subsidiary, Takeda Global Research...oday that the Arthritis Advisory Committee of the ...d that the FDA approve febuxostat for the treatme...e was 12 to zero in favor of approval, with one pa...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3TVA fertilizer technology used worldwide but few new products since 1970s 4597 1TVA fertilizer technology used worldwide but few new products since 1970s 4597 2TVA fertilizer technology used worldwide but few new products since 1970s 4597 3TVA fertilizer technology used worldwide but few new products since 1970s 4597 4Alcohol consumption can cause too much cell death fetal abnormalities 4594 1Alcohol consumption can cause too much cell death fetal abnormalities 4594 2CSL Behrings Innovative HeliTrax 28SM 29 System Helps Physicians Manage Hemophilia A Patients 7302 1CSL Behrings Innovative HeliTrax 28SM 29 System Helps Physicians Manage Hemophilia A Patients 7302 2CSL Behrings Innovative HeliTrax 28SM 29 System Helps Physicians Manage Hemophilia A Patients 7302 3CSL Behrings Innovative HeliTrax 28SM 29 System Helps Physicians Manage Hemophilia A Patients 7302 4VioQuest Pharmaceuticals Inc Q2 08 Review Issued by Scimitar Equity LLC 7299 1VioQuest Pharmaceuticals Inc Q2 08 Review Issued by Scimitar Equity LLC 7299 2
...iety for Investigative,Dermatology, FREEPORT, N.Y....tics today announced new clinical research that th...d in liposomes,enhances DNA repair and reduces MMP...data was presented at the 68th Annual,Meeting of t...12,in Los Angeles, CA. , "Our clinical study sugg...
...ty for Investigative Dermatology, FREEPORT, N.Y., ...y announced new comparative clinical data that ind...recognize, transport and,utilize L-ergothioneine (...importantly, that (EGT) acts as a more powerful an... reactive oxygen,species and reducing UV-induced h...
Other Medicine Technology:AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1,Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV,Irradiated Skin Cells 2AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
(Date:12/2/2008)... Orion Health announces that the SouthE...Juneau, Alaska, has selected the Rhapsody™ I... health record, radiology, pharmacy, laboratory an...t also plans to extend connectivity to statewide s...zation registry) and AKAIMS (an MIS and clinical d...
(Date:12/2/2008)... Liberty Mutual Provides Online Resourc...eSmart.com , Boston, MA ...nce and Holly Robinson Peete , actress, philanth...rage families to set aside a few moments before th...nd response plans at BeFireSmart.com. , , , , ,Ho...
(Date:12/2/2008)...c. 2 Population Service...sive project that could dramatically reduce the nu...aria. The program will provide free artemisinin-ba...munity health workers to poor children suspected o...treatment will be monitored to determine if it red...
(Date:12/1/2008)...d., Dec. 2 Patient satisfaction sc...the rise according to a new report,from Press Gan...ort: Patient,Perspectives on American Health Care...a driver for improvement in patient services. The...on patients treated at more than,1,200 outpatient...
Breaking Medicine News(10 mins):Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 3Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2
...orpyrifos-an insecticide, while in their mother’s ...or development by three years of age and also have...vation was made in a peer-reviewed study conducted...fos, which was banned for residential use in 2001,...
... second opinion is very vital for cancer patients ...nd it should surely be taken before undergoing// s...Cancer Center wanted to find out whether cancer di...pecialists. The records of 149 breast cancer patie...
...ce that can be inserted inside the lungs with the ...can help treat asthma, researchers conducting its/...espiratory system in which the airways constrict m...t its worst, asthma can be fatal. Though asthma c...
...aves of the University of Minnesota School of Publ...ents on a daily basis tend to have a healthier// l...ecember Journal of American Dietetic Association w...0 US high school seniors. They were analyzed for h...
Other Medicine News:Health News:Chlorpyrifos Affects Mental Development of Foetus 2Health News:Cancer? Get A Second Opinion 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: